Navigation Links
Amgen's Second Quarter 2013 Revenues Increased 5 Percent To $4.7 Billion And Adjusted Earnings Per Share (EPS) Increased 3 Percent To $1.89
Date:7/30/2013

#160; The Company uses these non-GAAP financial measures in connection with its own budgeting and financial planning.  These non-GAAP financial measures are in addition to, not a substitute for, or superior to, measures of financial performance prepared in conformity with GAAP.

About Amgen
Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe, effective medicines from lab to manufacturing plant to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, bone disease and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. For more information, visit www.amgen.com and follow us on www.twitter.com/amgen.

Forward-Looking Statements
This news release contains forward-looking statements that involve significant risks and uncertainties, including those discussed below and others that can be found in our Form 10-K for the year ended Dec. 31, 2012, and in any subsequent periodic reports on Form 10-Q and Form 8-K.  Amgen is providing this information as of the date of this news release and does not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise.

No forward-looking statement can be guaranteed and actual results may differ materially from those we project.  The Company's results may be affected by our ability to successfully market both new and existing products domestically and internationally, clinical and regulatory developments (domestic or foreign) involving curr
'/>"/>

SOURCE Amgen
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. Covance Reports Second Quarter Net Revenue of $592 Million, Pro Forma EPS of $0.78 and Record Adjusted Net Orders of $776 Million
2. Oncology remains most restrictive specialty for second year
3. China Biologic Products to Report Second Quarter 2013 Financial Results
4. Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2013 Second Quarter Financial Results
5. Vanda Pharmaceuticals to Announce Second Quarter 2013 Financial Results on July 31, 2013
6. Webcast Alert: Isis Pharmaceuticals Second Quarter 2013 Financial Results Conference Call
7. VirtualScopics Schedules Second Quarter 2013 Earnings Announcement
8. Luminex Corporation Reports Second Quarter 2013 Results
9. Endo to Announce Second Quarter 2013 Financial Results on August 6, 2013
10. Simcere Pharmaceutical Group to Announce Second Quarter 2013 Financial Results on Tuesday, August 13, 2013
11. PDI, Inc. to Hold Second Quarter 2013 Financial Results Conference Call on Monday, August 5, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)...   The New York Times sought out ... plastic surgeon, Dr. Rod Rohrich . Kybella, recently ... to reduce fat deposits under the chin. ... active ingredient in Kybella, deoxycholic acid, dissolves the fat ... to reshape this area without surgery. "So many consumers ...
(Date:5/4/2015)... May 4, 2015 Former NASA scientist ... last week where he discussed Theradome™, the first portable ... The FOX segment shows firsthand how, via laser technology, ... loss solution that will not require surgery or medication.  ... at the base of the hair follicle, which is ...
(Date:5/4/2015)... 4, 2015 Southfield Capital, a ... announced today that it completed a dividend ... specializes in the development and multi-channel deployment ... and biotechnology industries. Through the ... half of their invested capital and secured ...
Breaking Medicine Technology:Dr. Rod Rohrich Provides Medical Expertise on Kybella 2Dr. Rod Rohrich Provides Medical Expertise on Kybella 3FOX News Features Theradome as the Take-Home Solution to Tackle Baldness 2Southfield Capital and BioPharm Communications Announce Dividend Recapitalization 2
... ThermoGenesis Corp. (NASDAQ: KOOL ), a leading supplier ... stem cells, said today it will be participating in the ... The presentation by Matthew T. Plavan, Chief Financial Officer ... 11:15 a.m., Pacific Standard Time (2:15 p.m., Eastern Standard Time). ...
... SAN FRANCISCO, Calif., Jan. 5, 2012  Catalyst Biosciences, ... development of engineered proteases, today announced that Pfizer ... for PF-05280602, an investigational proprietary, engineered variant of ... PF-05280602 has been engineered to provide improved acute ...
Cached Medicine Technology:ThermoGenesis Announces Webcast of Presentation at OneMedForum Conference 2ThermoGenesis Announces Webcast of Presentation at OneMedForum Conference 3Pfizer Initiates Phase 1 Clinical Trial for FVIIa Hemophilia Drug Candidate Developed by Catalyst Biosciences 2
(Date:5/4/2015)... New York, NY (PRWEB) May 04, 2015 ... the 2015 International Champions Cup (ICC) . While ... the world and is held every four years, the International ... Last year, the tournament saw the all-time attendance record for ... Real Madrid from the Big House at the University of ...
(Date:5/4/2015)... City, OK and Seattle, WA (PRWEB) May 04, 2015 ... announced the formation of a collaboration to facilitate development ... number of ophthalmic disorders that lead to blindness, including ... to the MiDROPS™ formulation platform developed by EyeCRO, which ... the eye via a topical eyedrop. , Under ...
(Date:5/4/2015)... VA (PRWEB) May 04, 2015 Ticket Down ... at the John Paul Jones Arena in Charlottesville, VA. ... the history of the music business and this beloved performer ... Paul McCartney, the former member of two legendary groups: Wings ... in the music business since 2013 on the “Out There” ...
(Date:5/4/2015)... May 04, 2015 New findings released ... Tumor Association (ABTA) show that people diagnosed with a ... treatment options, including clinical trials, at the time of ... make difficult decisions about their course of treatment. The ... the first nationwide brain tumor volunteer network, the ABTA ...
(Date:5/4/2015)... 2015 Pricing Healthcare announces it ... one patient receiving care at St. George Surgical Center ... must be performed by July 15th, 2015, and the patient ... up front and forego the filing of insurance claims). , ... every year, and it devastates more and more individuals and ...
Breaking Medicine News(10 mins):Health News:Cheap 2015 International Champions Cup (ICC) Tickets: Ticket Down Slashes Ticket Prices on International Champions Cup (ICC) Presale Tickets 2Health News:Cheap 2015 International Champions Cup (ICC) Tickets: Ticket Down Slashes Ticket Prices on International Champions Cup (ICC) Presale Tickets 3Health News:Cheap 2015 International Champions Cup (ICC) Tickets: Ticket Down Slashes Ticket Prices on International Champions Cup (ICC) Presale Tickets 4Health News:EyeCRO and NeuMedics Announce Collaboration to Utilize MiDROPS™ Technology for the Development of NM108 2Health News:EyeCRO and NeuMedics Announce Collaboration to Utilize MiDROPS™ Technology for the Development of NM108 3Health News:Paul McCartney Tickets at John Paul Jones Arena in Charlottesville, VA: Ticket Down Slashes Paul McCartney Ticket Prices in Charlottesville at the John Paul Jones Arena 2Health News:American Brain Tumor Association Poll Underscores Need for Greater Awareness and Education at Time of Diagnosis 2Health News:American Brain Tumor Association Poll Underscores Need for Greater Awareness and Education at Time of Diagnosis 3Health News:Pricing Healthcare to Pay a Patient's Bill for a Procedure at Utah Facility 2Health News:Pricing Healthcare to Pay a Patient's Bill for a Procedure at Utah Facility 3
... in patients with metastatic breast cancer, especially in those ... epidermal growth factor receptor-2) positive, a surgical oncologist will ... Breast Cancer Conference (EBCC7). Dr Marie Sundquist, ... will say that the median survival times for five-year ...
... ... leading Pediatrician Dr. William Lawrence Jr. of Sixty Second Parent encouraged parents to continue ... ... National Nutrition Month draws to a close, leading Pediatrician Dr. William Lawrence Jr. of ...
... ... of Shimmering Resumes, offers to help former Bush speechwriter David Frum with his resume. ... strategy on healthcare reform. , ... (PRWEB) March 26, 2010 -- Paul Freiberger, the President of Shimmering Resumes, ...
... ... accidents , ... March 26, 2010 -- With the arrival of spring, more cyclists are planning to enjoy the ... people sharing the road with drivers and pedestrians., , , , ,This week bikers complained to ...
... ... disorders and improve dental procedures. , ... Miami, FLA. (PRWEB) -- In addition to cosmetic dentistry services, including veneers and ... Institute now offer dental massage to patients. Dr. Nassery teams up with Love Life Massage, ...
... Women who discover they have breast cancer while they ... the health of their unborn baby, according to research ... Conference (EBCC7) in Barcelona today (Friday). Dr Sibylle ... University of Frankfurt, Germany, and a member of the ...
Cached Medicine News:Health News:Survival in metastatic breast cancer patients is improving: targeted therapies have contributed 2Health News:Eating Habits Start Early - Parents must be Good Role Models for Healthy Kids 2Health News:President of Shimmering Resumes Offers Professional Resume To Bush Speechwriter, David Frum 2Health News:New York Personal Injury Attorney Interprets Increase in Tickets for Cyclists as Effort to Make Streets Safer 2Health News:Top Miami Dentist, Dr. Hamid Nassery, Offers Dental Massage Services For Patients 2Health News:Pregnant women can receive breast cancer chemotherapy without endangering health of their babies 2Health News:Pregnant women can receive breast cancer chemotherapy without endangering health of their babies 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: